Últimas noticias sobre UnitedHealth Group (NYSE:UNH) Bolsa

UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

trump-chart-shutter2

Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

AAPL

AMZN

AVGO

GOOGL

MELI

MRVL

MSFT

NVDA

PLTR

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSLA

XLRE

Select Sector SPDR-Consumer Discretionary

Los índices de EE.UU. rebotan tras avances en acuerdos comerciales. Nasdaq 100 lidera con un +3,4 %. Semiconductores y tecnológicas brillan.

Wall Street repunta tras declaraciones de Trump: Nasdaq 100 y S&amp;P 500 suben con fuerza

News

Markets

BMRA

RIVN

Mercados de EE.UU. bajan, con Apple, Tesla, Biomerica, Rivian y UnitedHealth destacando por movimientos clave en sus acciones.

Apple, Rivian, UnitedHealth, Biomerica, Tesla: 5 valores que están en el radar de los inversores

Pre-Market Outlook

Trading Ideas

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este jueves: BAC, SNV, MS, TSM y UNH.

5 acciones en el foco este jueves: BAC, SNV, MS, TSM y UNH

UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Inc

EC Healthcare

United Hampshire US REIT

<a href="https://www.wsj.com/articles/unitedhealth-group-sends-demands-for-hack-loan-repayments-9a26376c">UnitedHealth Group Sends Demands for Hack Loan Repayments - WSJ</a>

'UnitedHealth Group Sends Demands For Hack Loan Repayments; Insurer Threatens To Garnish Medical Reimbursements If Doctors Don't Repay Quickly' - WSJ

Truist Securities analyst David Macdonald maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Buy and raises the price target from $610 to $660.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on UnitedHealth Group, Raises Price Target to $660

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/04/09/final-trades-meta-unitedhealth-and-the-qqq.html">Halftime Report Final Trades</a>,&#8221; Stephen L. Weiss of Short Hills Capital Partners said Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is selling at a discount to the market, which it should never do. So, the growth is <a href="https://www.benzinga.com/quote/META/analyst-ratings">still there, he added.</a>
On Wednesday, Keybanc analyst Jason Celino maintained Meta with an Overweight rating and lowered the price target from $710 to $645, while B of A Securities analyst Justin Post maintained a Buy on the stock and cut the price target from $765 to $640.
Kari Firestone of Aureus Asset Management picked UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), which has been in its own bear market. She noted that the stock is now starting to improve and is not affected by tariffs.
Supporting her view, Mizuho analyst Ann Hynes, on Wednesday, maintained UnitedHealth Group with an Outperform rating and raised the price target from $600 to $650.
 Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Bryn Talkington of Requisite Capital Management also picked Meta.
Joseph M. Terranova of Virtus Investment Partners suggested buying some calls in Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) in case they bounce.
Price Action:
<ul>
<li>Meta shares gained 14.8% to close at $585.77 on Wednesday.</li>
<li>UnitedHealth shares rose 4.6% to close at $578.50 during Wednesday's session.</li>
<li>Invesco QQQ Trust jumped 12% during Wednesday's session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

Meta Platforms, UnitedHealth Group And More: CNBC's 'Final Trades'

Investors with a lot of money to spend have taken a bullish stance on UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UNH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 58 uncommon options trades for UnitedHealth Group.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 18%, bearish.
Out of all of the special options we uncovered, 23 are puts, for a total amount of $1,709,903, and 35 are calls, for a total amount of $6,126,227.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $240.0 to $610.0 for UnitedHealth Group over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in UnitedHealth Group's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to UnitedHealth Group's substantial trades, within a strike price spectrum from $240.0 to $610.0 over the preceding 30 days.
<h3>UnitedHealth Group Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744225368_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$339.0</td>
<td>$332.5</td>
<td>$332.5</td>
<td>$240.00</td>
<td>$1.6M</td>
<td>5.4K</td>
<td align="right">100</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$331.75</td>
<td>$328.5</td>
<td>$331.75</td>
<td>$240.00</td>
<td>$1.6M</td>
<td>5.4K</td>
<td align="right">50</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$328.0</td>
<td>$324.3</td>
<td>$328.0</td>
<td>$240.00</td>
<td>$820.0K</td>
<td>5.4K</td>
<td align="right">100</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$26.0</td>
<td>$24.3</td>
<td>$26.0</td>
<td>$610.00</td>
<td>$455.0K</td>
<td>82</td>
<td align="right">175</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$323.0</td>
<td>$320.75</td>
<td>$323.0</td>
<td>$240.00</td>
<td>$323.0K</td>
<td>5.4K</td>
<td align="right">215</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
<h3>UnitedHealth Group's Current Market Status</h3>
<ul>
<li>Trading volume stands at 8,791,011, with UNH's price up by 4.76%, positioned at $579.42.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>Professional Analyst Ratings for UnitedHealth Group</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $650.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on UnitedHealth Group with a target price of $650. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for UnitedHealth Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Unpacking the Latest Options Trading Trends in UnitedHealth Group

CNBC Halftime Report Final Trades: Meta Platforms, UnitedHealth Group, Invesco QQQ Trust, Series 1

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays cut Americold Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) price target from $26 to $21. Barclays analyst Anthony Powell upgraded the stock from Equal-Weight to Overweight. Americold Realty Trust shares closed at $17.50 on Tuesday. <a href="https://www.benzinga.com/quote/COLD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan slashed the price target for PTC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) from $210 to $160. JP Morgan analyst Alexei Gogolev downgraded the stock from Overweight to Neutral. PTC shares closed at $136.74 on Tuesday. <a href="https://www.benzinga.com/quote/PTC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies lowered Xenia Hotels &amp; Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) price target from $18 to $10. Jefferies analyst David Katz downgraded the stock from Buy to Hold. Xenia Hotels shares closed at $9.22 on Tuesday. <a href="https://www.benzinga.com/quote/XHR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) from $132 to $122. Piper Sandler analyst Paul Newsome maintained an Overweight rating. Goosehead Insurance shares closed at $103.90 on Tuesday. <a href="https://www.benzinga.com/quote/GSHD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer cut the price target for Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) from $24 to $19. Oppenheimer analyst Brian Schwartz maintained an Outperform rating. Freshworks shares closed at $12.08 on Tuesday. <a href="https://www.benzinga.com/quote/FRSH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) price target from $600 to $650. Mizuho analyst Ann Hynes maintained an Outperform rating. UnitedHealth shares settled at $553.08 on Tuesday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $17 to $16. Morgan Stanley analyst Alex Straton maintained an Equal-Weight rating. Levi Strauss shares closed at $12.42 on Tuesday. <a href="https://www.benzinga.com/quote/LEVI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho slashed Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) price target from $285 to $255. Mizuho analyst James Lee maintained an Outperform rating. Amazon shares closed at $170.66 on Tuesday.  <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from $154 to $126. BMO Capital analyst John McNulty maintained an Outperform rating. RPM shares settled at $96.97 on Tuesday. <a href="https://www.benzinga.com/quote/RPM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs raised Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) price target from $157 to $172. Goldman Sachs analyst Asad Haider upgraded the stock from Neutral to Buy. Johnson &amp; Johnson shares closed at $150.00 on Tuesday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AMZN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png" alt="" class="wp-image-863746" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53.png 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

COLD

FRSH

GSHD

LEVI

Amazon.com To $255? Here Are 10 Top Analyst Forecasts For Wednesday

Mizuho analyst Ann Hynes maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Outperform and raises the price target from $600 to $650.

Mizuho Maintains Outperform on UnitedHealth Group, Raises Price Target to $650

Market Summary

General

Benzinga Market Summary: S&P Falls Below 5,000 Amid US-China Trade Tensions Ahead Of China Tariff Deadline, Chip Stocks Fall, Health Insurers Spike On Increased Payment Rates To Medicare Insurers

U.S. stocks staged a broad-based rally on Monday, snapping a volatile losing streak after President Donald Trump hinted at a more diplomatic <a href="https://www.benzinga.com/topic/tariffs">approach to tariff negotiations.</a>
In a post on Truth Social, Trump said the U.S. is handling a "massive amount of requests for negotiations," referencing active talks with South Korea and hinting that China "wants to make a deal, badly."
He also mentioned a joint venture involving an Alaska pipeline and military cost-sharing, asserting that South Korea&#8217;s top negotiation team was en route to the U.S.
Meanwhile, Fed speakers begin to highlight the negative economic impact from tariffs. &#8220;We can&#8217;t really wait to the end of the quarter plus one month before we find out that investment really dropped off and GDP growth is shrinking,&#8221; Chicago Fed President Austan Goolsbee said.
By midday trading in New York, all major U.S. stock indices were firmly in the green. The S&amp;P 500 rose 1.4%, the Dow Jones Industrial Average gained 1.1%, and the tech-heavy Nasdaq Composite led with a 1.8% jump. Technology stocks were the day's clear outperformers, driven by a strong rebound in the semiconductor sector.
The iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) surged 3.3%, marking its strongest intraday gain since September 2024. Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) led the charge with a 7.3% jump, followed by Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) and Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), which both climbed 6.1%.
In commodities, gold prices rose 0.5% to $2,335 per ounce, poised to snap a three-session losing streak. Oil prices also saw a firm recovery, with WTI crude advancing 1.5% to $61.50 per barrel, reversing recent weakness. U.S. Treasury yields remained largely flat. 
In contrast, cryptocurrency markets failed to participate in the rally. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell another 1% to $78,000. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,781.63</td>
<td>2.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,718.65</td>
<td>2.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,144.86</td>
<td>1.6%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,821.21</td>
<td>0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:20 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1.8% to $513.37.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rallied 2% to $387.02.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 1.9% to $431.23.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.4% higher to 180.33.</li>
<li>The&nbsp;Financials&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) outperformed, up 2.5%; the&nbsp;Materials&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) lagged, down 0.1%.</li>
</ul>
<h1 class="wp-block-heading">S&amp;P 500&#8217;s Top 5 Performers</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Chg %</td>
</tr>
<tr>
<td>Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>)</td>
<td>9.93%</td>
</tr>
<tr>
<td>Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>)</td>
<td>8.15%</td>
</tr>
<tr>
<td>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>)</td>
<td>6.48%</td>
</tr>
<tr>
<td>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) </td>
<td>5.98%</td>
</tr>
<tr>
<td>Western Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>)</td>
<td>5.77%</td>
</tr>
</tbody>
</table>
</figure>
<h1 class="wp-block-heading">S&amp;P 500&#8217;s Worst 5 Losers</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Chg %</td>
</tr>
<tr>
<td>Albemarle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>)</td>
<td>-8.18%</td>
</tr>
<tr>
<td>lululemon athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>)</td>
<td>-4.53%</td>
</tr>
<tr>
<td>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)</td>
<td>-4.39%</td>
</tr>
<tr>
<td>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</td>
<td>-3.97%</td>
</tr>
<tr>
<td>Ralph Lauren Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>-3.50%</td>
</tr>
</tbody>
</table>
</figure>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44696476/ups-expands-delivery-options-with-two-new-ground-services">UPS Expands Delivery Options With Two New Ground Services</a></li>
</ul>
Photo: Shutterstock

Government

Federal Reserve

Tech

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

LULU

SNDK

Stocks Rebound, Chipmakers Soar On Trade Deal Hopes, Bitcoin Lags: What's Driving Markets Tuesday?

Benzinga Market Summary: S&P Rebounds, 10-Year Rises, Health Insurers Spike On Increased Payment Rates To Medicare Insurers

U.S. stocks surged in early trading Tuesday after President Donald Trump hinted at progress on some trade deals with key trading partners, easing fears of global trade disruption stemming <a href="https://www.benzinga.com/topic/tariffs">from recent tariff announcements.</a>
The S&amp;P 500 index, as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), surged 3% by 9:45 a.m. in New York, clawing back some of the 10% it had lost over the previous four sessions.
Other major indices also showed robust gains, with the tech-heavy Nasdaq 100 – tracked by the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) – outperforming counterparts amid broad-based rallies in mega-cap and semiconductor stocks.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
<td>%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,025.43</td>
<td>+594.75</td>
<td>3.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,121.15</td>
<td>+1,155.55</td>
<td>3.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,213.82</td>
<td>+151.57</td>
<td>3.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,858.95</td>
<td>+48.84</td>
<td>2.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 9:45 a.m. ET</figcaption></figure>
After suffering steep losses in recent sessions, investors poured back into financials, tech, and consumer discretionary, which were the top-performing sectors on Tuesday. 
Semiconductors were the standout industry group, with the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) rallying 4.5%.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>S&amp;P Sector ETFs</td>
<td>%</td>
</tr>
<tr>
<td>Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>4.0%</td>
</tr>
<tr>
<td>Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>3.8%</td>
</tr>
<tr>
<td>Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>3.0%</td>
</tr>
<tr>
<td>Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>2.9%</td>
</tr>
<tr>
<td>Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>2.7%</td>
</tr>
<tr>
<td>Industrials&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>2.7%</td>
</tr>
<tr>
<td>Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>1.8%</td>
</tr>
<tr>
<td>Real Estate&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>1.4%</td>
</tr>
<tr>
<td>Materials&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>1.4%</td>
</tr>
<tr>
<td>Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>1.3%</td>
</tr>
<tr>
<td>Consumer Staples&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>1.2%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Trump Sparks Optimism With Trade Talk Blitz</h3>
The catalyst behind the rally was a lengthy post on Truth Social by Trump, in which he described a "great call" with South Korea's acting president. 
The president said South Korea is sending a "top team" to the U.S. for negotiations, calling the process &#8220;one-stop shopping&#8221; for trade and military agreements.
In a <a href="https://edition.cnn.com/2025/04/08/asia/south-korea-acting-president-han-interview-intl-hnk/index.html">CNN</a> interview, South Korea&#8217;s acting president confirmed the country would not align with China and Japan to counter U.S. tariffs. 
Seoul faces 25% tariffs under Trump's global tariff rollout. Instead, it aims to strike a bilateral agreement with the U.S. to avoid a blow to its export-driven economy.
Trump also hinted at more openness in trade negotiations with China after threatening Monday to impose a 50% tariff on top of the 54% already levied.
&#8220;China also wants to make a deal, badly, but they don&#8217;t know how to get it started,&#8221; Trump wrote.
&#8220;We are waiting for their [China's] call. It will happen!&#8221; he added, suggesting renewed momentum on U.S.-China trade talks.
Senior White House economic adviser Kevin Hassett echoed the optimism, telling Fox News that the Trump administration is focusing on countries with "large trade deficits" with the U.S. He emphasized that "fair and reciprocal trade" remains the administration&#8217;s goal.
<h3 class="wp-block-heading">Mega-cap stocks (S&amp;P 100): Top 7 performers</h3>
Among S&amp;P 100 companies, CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) led gains with a 9.26% surge, followed by Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>).
<figure class="wp-block-table"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Last</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS Health Corp. </td>
<td>69.76</td>
<td>+9.26%</td>
</tr>
<tr>
<td>Broadcom Inc.</td>
<td>168.07</td>
<td>+9.04%</td>
</tr>
<tr>
<td>UnitedHealth Group Inc. </td>
<td>563.81</td>
<td>+7.45%</td>
</tr>
<tr>
<td>NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>104.71</td>
<td>+7.24%</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>545.01</td>
<td>+5.57%</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>246.28</td>
<td>+5.57%</td>
</tr>
<tr>
<td>JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>)</td>
<td>226.30</td>
<td>+5.53%</td>
</tr>
</tbody>
</table>
</figure>
The biggest market-moving headline of the session was the explosive increase in market capitalization among the Magnificent Seven — Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Meta Platforms Inc., Tesla Inc., and NVIDIA Corp. — which collectively added over $564 billion in market value.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Company</td>
<td>Market Cap gain</td>
</tr>
<tr>
<td>NVIDIA</td>
<td>$165.82 B</td>
</tr>
<tr>
<td>Apple</td>
<td>$92.40 B</td>
</tr>
<tr>
<td>Microsoft</td>
<td>$85.39 B</td>
</tr>
<tr>
<td>Amazon</td>
<td>$70.02 B</td>
</tr>
<tr>
<td>Meta Platforms </td>
<td>$67.36 B</td>
</tr>
<tr>
<td>Alphabet (Google)</td>
<td>$48.48 B</td>
</tr>
<tr>
<td>Tesla</td>
<td>$35.19 B</td>
</tr>
</tbody>
<tfoot>
<tr>
<td>Total Market Cap Gain </td>
<td> $564.66 billion</td>
</tr>
</tfoot>
</table>
</figure>
<h3 class="wp-block-heading">Nasdaq 100: Standout Performers</h3>
AppLovin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) was the top gainer in the Nasdaq 100, soaring 10.62%, while Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) and Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) followed with strong moves.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Last</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>AppLovin Corp. </td>
<td>256.89</td>
<td>+10.62%</td>
</tr>
<tr>
<td>Marvell Technology Inc. </td>
<td>55.76</td>
<td>+9.34%</td>
</tr>
<tr>
<td>Broadcom Inc. </td>
<td>168.19</td>
<td>+9.12%</td>
</tr>
<tr>
<td>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)</td>
<td>84.79</td>
<td>+8.93%</td>
</tr>
<tr>
<td>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>)</td>
<td>95.91</td>
<td>+8.21%</td>
</tr>
<tr>
<td>NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>104.65</td>
<td>+7.18%</td>
</tr>
<tr>
<td>MercadoLibre Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>)</td>
<td>1,921.14</td>
<td>+7.04%</td>
</tr>
</tbody>
</table>
</figure>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44685614/treasury-secretary-bessent-says-china-holds-losing-hand-in-tariff-escalation">Treasury Secretary Bessent Says China Holds &#8216;Losing Hand&#8217; In Tariff Escalation</a></li>
</ul>
Image created using photos from Shutterstock.

Wall Street Soars As Trump Teases Trade Deals, Magnificent 7 Add Over $500 Billion In Market Value

WIIM

ALHC

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Shares of health insurers are trading higher following a WSJ report indicating the Trump administration will increase Medicare Advantage rates.

Health insurer stocks are trading higher after the market close on Monday following a report indicating the Trump administration will increase payment rates <a href="https://www.benzinga.com/topic/medicare">for Medicare insurers</a>.
What Happened: The Centers for Medicare and Medicaid Services (CMS) announced Monday that it will increase payment rates for Medicare insurers to 5.06%. The rate is well above the 2.23% proposed by the Biden administration and above all prior analyst expectations, according to the <a href="https://www.wsj.com/health/healthcare/private-medicare-plans-to-get-big-payment-boost-from-trump-administration-017d9aaa">Wall Street Journal</a>.
The report indicates that investors are expected to view the increase as a show of support from the Trump administration for Medicare Advantage, under which private companies can offer Medicare-approved insurance plans. 
&#8220;By finalizing these payment policies, CMS is ensuring that Medicare Advantage continues to offer access to critical services in an efficient, accountable manner, further strengthening the program's ability to serve beneficiaries,&#8221; the Medicare agency <a href="https://www.cms.gov/newsroom/press-releases/cms-finalizes-2026-payment-policy-updates-medicare-advantage-and-part-d-programs">said</a> in a press release.
The new head of CMS Mehmet Oz has long been a supporter of private insurance plans in Medicare, according to the Wall Street Journal. CMS reportedly said the payment rate increase reflects higher medical costs. 
&#8220;The actions taken by CMS help protect beneficiaries and taxpayers from waste, fraud, and abuse, while also driving access to high-quality, affordable healthcare through Medicare Advantage,&#8221; CMS said.
Here&#8217;s a look at some of the health insurer stocks making big moves following the announcement:
<ul>
<li>CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) up 6.50% at $68</li>
</ul>
<ul>
<li>UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) up 5.77% at $555</li>
</ul>
<ul>
<li>Humana Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) up 12.08% at $285.49</li>
</ul>
<ul>
<li>Elevance Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) up 6.35% at $450</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a></li>
</ul>
Photo: Shutterstock.

Health Care

After-Hours Center

Movers

Health Insurers Surge After Medicare Agency Increases Payment Rates

Shares of health insurers are trading higher following a WSJ report indicating the Trump administration will increase payment rates for Medicare insurers.

<a href="https://www.wsj.com/health/healthcare/private-medicare-plans-to-get-big-payment-boost-from-trump-administration-017d9aaa" title="https://www.wsj.com/health/healthcare/private-medicare-plans-to-get-big-payment-boost-from-trump-administration-017d9aaa">https://www.wsj.com/health/healthcare/private-medicare-plans-to-get-big-payment-boost-from-trump-administration-017d9aaa</a>

WSJ: 'Medicare Advantage plans will get a 5.06% rate increase, well above the 2.23% bump that the Biden administration proposed'

Shares of the Health Care Select Sector SPDR Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NASDAQ">XLV</a>) are trading lower by 8.6% to $132.86 over the past week as tariff announcements from President Donald Trump last week spooked investors and <a href="https://www.benzinga.com/government/regulations/25/04/44670193/wall-street-turmoil-deepens-as-trump-threatens-massive-china-tariffs-bitcoin-wobbles-at-78k-whats-driving-markets-monday">dragged major sectors</a> of the market lower. 
While healthcare is often viewed as a defensive play during times of uncertainty, the <a href="https://www.benzinga.com/general/health-care">sector</a> is not immune to the broader economic implications of escalating trade tensions.
<h2 class="wp-block-heading">What Is XLV?</h2>
The Health Care Select Sector SPDR Fund is an exchange-traded fund that tracks the performance of the Health Care Select Sector Index, which includes large U.S. healthcare companies across pharmaceuticals, biotechnology, healthcare equipment and managed care. Top holdings include Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), Pfizer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) and Merck &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) .
Although healthcare demand tends to be less cyclical than sectors like industrials or energy, many of XLV's components are <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44667104/speculators-raise-wagers-on-fed-emergency-rate-cuts-as-theories-of-self-induced-crash-gather-pace">exposed to global markets</a>, supply chains and regulatory dynamics—all of which can be disrupted by a trade war.
Read Also: <a href="https://www.benzinga.com/news/25/04/44670684/whats-going-on-with-financial-select-sector-spdr-fund-xlf">What&#8217;s Going On With Financial Select Sector SPDR Fund (XLF)?</a>
<h2 class="wp-block-heading">Why Are Tariffs Hitting Healthcare—and XLV?</h2>
At first glance, healthcare might seem like an unlikely victim of tariff tensions, but the industry is more globally interconnected than it appears. Here's how tariff escalation is weighing on XLV and its underlying holdings:
<ul>
<li>Global Supply Chain Disruptions: Many medical devices and pharmaceutical ingredients are manufactured or sourced overseas. Tariffs on imported materials from countries like China can increase production costs for companies like Medtronic and Abbott Laboratories, which rely on <a href="https://www.benzinga.com/25/04/44663112/us-families-to-see-3800-annual-price-hike-says-experts-even-as-trump-indicates-tariff-windfall-of-tens-of-billions-of-dollars">international supply chains</a> to maintain margins and deliver products at scale. </li>
<li>Pricing Pressures Intensify: Healthcare companies already face intense political scrutiny over pricing. Tariffs add another <a href="https://www.benzinga.com/news/global/25/04/44668830/we-want-fairness-white-house-trade-adviser-navarro-says-trump-administration-is-focused-on-non-tariff-cheating">layer of cost inflation</a> that may be difficult to pass along to consumers or insurers. That's especially challenging for drugmakers and device manufacturers that operate under tight pricing regulations or depend on long-term contracts. </li>
<li>Global Growth Matters: Multinational pharmaceutical companies such as Pfizer and Johnson &amp; Johnson derive a significant share of their revenue from international markets. A slowdown in global economic growth due to <a href="https://www.benzinga.com/25/04/44661965/trumps-reciprocal-tariff-threat-wipes-out-nearly-18-trillion-from-magnificent-7-dan-ives-warns-it-could-set-us-tech-back-a-decade-investors-know-math-and-the-sad-reality">trade tensions</a> can dampen demand for branded drugs and medical products abroad, squeezing top-line growth. </li>
<li>Market Volatility Hits Sentiment: Even though healthcare is traditionally considered defensive, the sector is still susceptible to broader market moves. Investors often rotate out of equities—including healthcare—during times of heightened uncertainty. Additionally, biotech and life sciences stocks, many of which are included in XLV, tend to be more volatile and sensitive to shifts in investor risk appetite.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44670193/wall-street-turmoil-deepens-as-trump-threatens-massive-china-tariffs-bitcoin-wobbles-at-78k-whats-driving-markets-monday">Wall Street Turmoil Deepens As Trump Threatens Massive China Tariffs, Bitcoin Wobbles At $78K: What&#8217;s Driving Markets Monday?</a>

Why Health Care Select Sector SPDR Fund (XLV) Is Moving

Live On CNBC, Jim Lebenthal Announces Sold UnitedHealth Group

For many investors, dividend-focused <a href="https://in.benzinga.com/25/03/44565770/30-year-old-with-65k-in-stocks-sparks-debate-focusing-mostly-on-etfs-but-now-betting-on-bonds-small-caps-and-international-plays">stocks</a> and funds provide a way to generate passive income, whether to supplement retirement, cover day-to-day <a href="https://in.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">expenses</a>, or even finance small luxuries like annual vacations.
While some aim for significant <a href="https://in.benzinga.com/personal-finance/25/03/44518501/20-year-old-university-student-wants-help-with-buying-dividend-stocks-whats-the-best-way-to-start-reddit-weights-in">dividend</a> payouts to replace their salary, others are happy with modest but constant returns that offer a little extra financial freedom.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
This is the case of a Reddit user who is exploring this approach. With $30,000 to invest, he's seeking long-term dividend stocks that can grow over the next 20 years until retirement. While he already holds dividend-paying stocks like Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Walt Disney&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), he wants to expand his portfolio for stability and future income, even if it's just enough to cover yearly vacations.
&#8220;I currently have some stocks that give out dividends (Apple, Disney) but I&#8217;m looking for others. Long-term stability, that my wife and I can use the dividends as another form of income say in 20 years. Even if it&#8217;s just enough to pay for a yearly vacation here or there. Any thoughts on good companies to choose from?&#8221; he asked.
Let&#8217;s break down the Redditors&#8217; advice received in the comment section.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">Where to Invest $30,000 to Generate Enough Income to Cover Yearly Vacations? Reddit Answers</h2>
Put the Money in an ETF
Several commenters recommended Schwab U.S. Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) as a core holding because of its dividend yield, historical growth, and the low-risk, diversified exposure it offers investors.
&#8220;Go all in SCHD. Low risk, nice 3.5% starting yield and it will just keep growing,&#8221; a commenter said.
Reinforcing the idea that SCHD fits the poster&#8217;s long-term stability and dividend payout need, this Redditor also suggested he goes with SCHD: &#8220;Since you want some growth and decent payout, SCHD is a great option. 3.5% dividends and 11% growth over the last 10 years each year.&#8221;
&#8220;I would stick with S&amp;P 500 ETFs being young. Put it in a self-direct investment retirement account to avoid taxes,&#8221; a comment reads.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Consider High-Yield Dividend Stocks and Trusts
Several commenters suggested higher-yield assets that would generate higher payouts for the investor in the long run.
&#8220;If you want higher yield stocks check: [Verizon Communications (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>)], [AT&amp;T (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>)], [Realty Income Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/o#NYSE">O</a>)], [Altria Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)], [British American Tobacco (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bti#NYSE">BTI</a>)],&#8221; a Redditor recommended.
A commenter mentioned United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) as a great pick since the company seems to start focusing on higher profit margin areas.
&#8220;UPS pays a solid dividend and the share price has been beaten down a lot on the news that they are reducing Amazon deliveries to focus on higher profit margin areas,&#8221; he said.
Suggesting a very detailed portfolio allocation, this Redditor mentioned several ETFs and individual stocks that he considers would help the poster reach his dividend and growth goals.
&#8220;[Vanguard S&amp;P 500 ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voo#NYSE">VOO</a>)] $5,000, 1.25% dividends. Do [dividend reinvestment plan] SCHD $5,000, 3.5% dividends. Do [dividend reinvestment plan], [JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)], [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)​] ($5,000), 8% combined dividends. Do [dividend reinvestment plan] [Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>)] $2,000, 3% dividends. Do [dividend reinvestment plan] [Waste Management (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wm#NYSE">WM</a>)] and [Automatic Data Processing (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adp#NASDAQ">ADP</a>)] ($3,000), 2% average dividend. Do [dividend reinvestment plan] [Pfizer (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>)] and [Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>)] $2,000, 4.75% average dividend. Do [dividend reinvestment plan] [JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>)] and [UnitedHealth Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>)] $2,000, 2% average dividends. Do [dividend reinvestment plan] AAPL and [Microsoft (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>)] $2,000. [The Coca-Cola Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>)] and MO $2,000, 5% average dividends. Do [dividend reinvestment plan] JPM or [American Express (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axp#NYSE">AXP</a>)] $2,000. JPM has good potential growth,&#8221; the suggestion says.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

JEPI

JEPQ

SCHD

Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts

In September, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) Caremark, Cigna Corp&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) Express Scripts, and UnitedHealth Group Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the list <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">price of insulin medications</a>.
The&nbsp;complaint&nbsp;accuses the PBMs of creating a system that benefits them financially by prioritizing drug rebates, forcing patients to pay higher costs for life-saving insulin. These PBMs, referred to as the Big Three, administer around 80% of <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40964870/us-federal-trade-commission-sues-cvs-health-cigna-unitedhealths-pharmacy-benefit-managers-for-infl" rel="noreferrer noopener">prescriptions in the U.S</a>.
The FTC is now pausing after the agency submitted <a href="https://www.ftc.gov/system/files/ftc_gov/pdf/d9437_2025.04.01_commorderstayingadjudication.pdf" target="_blank" rel="noreferrer noopener">an order</a> seeking an administrative stay in the case.
Also Read:<a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43010888/ftc-says-unitedhealth-cvs-cigna-make-billions-via-pbms-on-specialty-drugs" rel="noreferrer noopener"> FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs</a>
The agency does not cite any sitting commissioners who can join the proceedings. The two sitting commissioners, Republicans Andrew Ferguson and Melissa Holyoak, <a href="https://www.benzinga.com/government/24/10/41172976/texas-attorney-general-sues-insulin-manufacturers-and-pharmacy-benefit-managers-over-price-fixing-co" target="_blank" rel="noreferrer noopener">have recused themselves</a>.
According to the order filed this week, the stay will remain in place for at least 105 days. The courts also set an evidentiary hearing for 225 days after the stay lifts.
Reuters notes that of its five sitting commissioners, two were fired, two were removed from the case, and one resigned when Trump took office.
Several state and local governments also filed lawsuits against drug companies and pharmacy benefit managers, accusing them <a target="_blank" href="https://www.benzinga.com/markets/equities/24/08/40560002/governments-suing-pharmacy-benefit-managers-over-insulin-prices-have-long-benefited-from-their-r" rel="noreferrer noopener">of inflating insulin prices</a>.
In November 2024, the FTC faced legal challenges from three competing pharmacy-benefit managers over its attempt to restrict their ability to negotiate drug prices for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/24/11/42097386/cvs-healthcignaunitedhealths-pharmacy-benefit-managers-accuse-ftc-of-overreach-in-effort-to-reshape-drug-rebate-system" rel="noreferrer noopener">health plan sponsors</a>.
The PBMs argue that this action seeks to upend current drug rebate contracts and disrupt long-standing practices, all while expanding the FTC&#8217;s authority beyond traditional limits.
The companies also&nbsp;contend&nbsp;that the administrative proceeding violates constitutional principles by lacking independent judicial oversight and claim that the FTC&#8217;s approach could result in significant and irreparable injury.
Price Action: CI stock is down 1.13% at $328.16, UNH stock is up 0.04% at $523.40, and CVS stock is down 0.85% at $67.49&nbsp;during the premarket session at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44614073/sportradars-big-bet-on-sports-data-analyst-raises-2026-forecast-sees-major-growth-in-live-betting" target="_blank" rel="noreferrer noopener">Sportradar&#8217;s Bets Big On Sports Data, Analyst Says Company Has Favorable Setup</a></li>
</ul>
Image: Shutterstock

Legal

FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/03/28/final-trades-paypal-meta-abbvie-and-snowflake.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management said Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) continues to move toward record high levels and the <a href="https://www.benzinga.com/quote/KNSL/analyst-ratings">stock looks &#8220;great.&#8221;</a>
Supporting his view, Truist Securities analyst Mark Hughes, on Feb. 18, maintained Kinsale Cap Group with a Buy rating and raised the price target from $480 to $525.
Jim Lebenthal of Cerity Partners picked PG&amp;E Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>), a North California utility.
On the earnings front, PG&amp;E will hold a conference call on Thursday, April 24, to discuss its first quarter 2025 results. Analysts expect the company to report quarterly earnings at 40 cents per share, up from 37 cents per share in the year-ago period. PG&amp;E projects quarterly revenue of $6.23 billion, compared to $5.86 billion a year earlier.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Stephanie Link of Hightower Advisors named UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) as her final trade.
UnitedHealth Group will release its first quarter financial results before the opening bell on Thursday, April 17. Analysts expect the healthcare company to report quarterly earnings at $7.31 per share, up from $6.91 per share in the year-ago period. UnitedHealth projects quarterly revenue of $111.6 billion, compared to $99.8 billion a year earlier.
Price Action:
<ul>
<li>Kinsale Capital gained 0.3% to close at $488.15 on Tuesday.</li>
<li>PG&amp;E Corporation shares rose 0.5% to close at $17.27 during Tuesday's session.</li>
<li>UnitedHealth Group shares slipped 0.1% to settle at $523.12 on Tuesday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44584246/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo: Shutterstock

KNSL

UnitedHealth Group, PG&E And A Financial Stock On CNBC's 'Final Trades'

Press Releases

AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of UnitedHealth Group Incorporated - UNH

UnitedHealth Group Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH

Optum Rx Further Simplifies Consumer Access to Prescription Drugs

Optum Rx to Modernize Pharmacy Payment Models

UnitedHealth Group Announces Earnings Release Date

UNH Announcement: UnitedHealth Group Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH

Comments

UnitedHealth Group

Noticias

Últimas noticias sobre UnitedHealth Group (NYSE:UNH) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL